These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10613387)

  • 1. An individualized, sensitive frequency range for early detection of ototoxicity.
    Fausti SA; Henry JA; Helt WJ; Phillips DS; Frey RH; Noffsinger D; Larson VD; Fowler CG
    Ear Hear; 1999 Dec; 20(6):497-505. PubMed ID: 10613387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-frequency audiometric monitoring strategies for early detection of ototoxicity.
    Fausti SA; Larson VD; Noffsinger D; Wilson RH; Phillips DS; Fowler CG
    Ear Hear; 1994 Jun; 15(3):232-9. PubMed ID: 8076721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of ototoxicity using 1/6th-octave steps.
    Fausti SA; Helt WJ; Phillips DS; Gordon JS; Bratt GW; Sugiura KM; Noffsinger D
    J Am Acad Audiol; 2003 Oct; 14(8):444-50. PubMed ID: 14655957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity.
    Fausti SA; Henry JA; Schaffer HI; Olson DJ; Frey RH; McDonald WJ
    J Infect Dis; 1992 Jun; 165(6):1026-32. PubMed ID: 1583319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies.
    Fausti SA; Rappaport BZ; Schechter MA; Frey RH; Ward TT; Brummett RE
    Am J Otolaryngol; 1984; 5(3):177-82. PubMed ID: 6742338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrasubject reliability of high-frequency (9-14 kHz) thresholds: tested separately vs. following conventional-frequency testing.
    Fausti SA; Henry JA; Hayden D; Phillips DS; Frey RH
    J Am Acad Audiol; 1998 Apr; 9(2):147-52. PubMed ID: 9564678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.
    Konrad-Martin D; James KE; Gordon JS; Reavis KM; Phillips DS; Bratt GW; Fausti SA
    J Am Acad Audiol; 2010 May; 21(5):301-14; quiz 357. PubMed ID: 20569665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Dinopoulou D; Vossinakis I; Tsakanikos M; Douniadakis D
    Int J Pediatr Otorhinolaryngol; 1999 Nov; 50(3):177-84. PubMed ID: 10595663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-frequency (8 to 16 kHz) reference thresholds and intrasubject threshold variability relative to ototoxicity criteria using a Sennheiser HDA 200 earphone.
    Frank T
    Ear Hear; 2001 Apr; 22(2):161-8. PubMed ID: 11324845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-frequency monitoring for early detection of cisplatin ototoxicity.
    Fausti SA; Henry JA; Schaffer HI; Olson DJ; Frey RH; Bagby GC
    Arch Otolaryngol Head Neck Surg; 1993 Jun; 119(6):661-6. PubMed ID: 8499098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
    Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-Level Frequency Threshold Testing for Ototoxicity Monitoring.
    Rieke CC; Clavier OH; Allen LV; Anderson AP; Brooks CA; Fellows AM; Brungart DS; Buckey JC
    Ear Hear; 2017; 38(6):e369-e375. PubMed ID: 28362673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ototoxicity of aminoglycoside antibiotics in animal study.
    Sato K
    Adv Otorhinolaryngol; 1983; 29():145-50. PubMed ID: 6601360
    [No Abstract]   [Full Text] [Related]  

  • 15. High-frequency testing techniques and instrumentation for early detection of ototoxicity.
    Fausti SA; Frey RH; Henry JA; Olson DJ; Schaffer HI
    J Rehabil Res Dev; 1993; 30(3):333-41. PubMed ID: 8126658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ototoxicity of aminoglycoside antibiotics].
    Reiss M; Reiss G
    Praxis (Bern 1994); 2003 Jan; 92(4):127-33. PubMed ID: 12632843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended High-Frequency Audiometry for Ototoxicity Monitoring: A Longitudinal Evaluation of Drug-Resistant Tuberculosis Treatment.
    Stevenson LJ; Biagio-de Jager L; Graham MA; Swanepoel W
    Am J Audiol; 2023 Mar; 32(1):70-80. PubMed ID: 36490390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
    Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-frequency pure-tone audiometry in children: a test-retest reliability study relative to ototoxic criteria.
    Beahan N; Kei J; Driscoll C; Charles B; Khan A
    Ear Hear; 2012; 33(1):104-11. PubMed ID: 21760512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.